Product Summary
OL-TAP 200 MG TABLET contains Tapentadol 200 mg in an extended-release (ER) formulation. Tapentadol is a centrally acting analgesic with two principal pharmacological actions: mu-opioid receptor agonism and norepinephrine reuptake inhibition. The ER formulation is designed to provide prolonged drug release rather than the immediate delivery associated with conventional tablets. Because tapentadol is an opioid medicine, OL-TAP 200 MG TABLET is a prescription-controlled medicine and should be used strictly under qualified medical supervision.
Product Full Description
OL-TAP 200 MG TABLET contains Tapentadol 200 mg in an extended-release formulation.
Tapentadol combines mu-opioid receptor activity with inhibition of norepinephrine reuptake.
These complementary pharmacological actions contribute to its centrally acting analgesic effects.
The ER formulation releases the active ingredient gradually over an extended period.
The 200 mg strength represents a higher-strength extended-release formulation intended for carefully individualized prescribing.
Tapentadol ER must be taken exactly as directed because inappropriate use of modified-release opioids can present significant risks.
Usage Instructions
Take OL-TAP 200 MG TABLET exactly according to your doctor's prescription.
Swallow the tablet whole with sufficient water.
Do not crush, chew, dissolve, or split the extended-release tablet unless the specific product information expressly permits it.
Take doses at the prescribed intervals and do not take additional tablets without medical authorization.
Do not independently increase, decrease, or change the dosing schedule.
If a dose is missed, follow the instructions provided by your prescribing healthcare professional.
Do not discontinue long-term opioid treatment abruptly without medical guidance.
Medicinal Advantages
Extended-release formulation: Designed for gradual delivery of Tapentadol over an extended period.
Dual pharmacological activity: Tapentadol acts as a mu-opioid receptor agonist and norepinephrine reuptake inhibitor.
Centrally acting analgesic: Works through mechanisms within the central nervous system.
200 mg strength: Provides a high-strength ER formulation for carefully individualized prescribing.
Controlled dosing: The prolonged-release design can provide sustained exposure when used according to an appropriate medical regimen.
Mechanism of Action
Tapentadol has a dual mechanism of action. It acts as an agonist at mu-opioid receptors (MOR) while also inhibiting the reuptake of norepinephrine. Mu-opioid receptor activity influences central pain-processing pathways, while increased norepinephrine availability contributes to descending inhibitory control of pain transmission. The combined pharmacological actions contribute to Tapentadol's analgesic activity.
The extended-release formulation is designed to release Tapentadol progressively, producing a more sustained exposure than an immediate-release formulation.
Off-Label Uses
Tapentadol ER may occasionally be prescribed outside officially approved uses in selected clinical circumstances based on a healthcare professional's judgment. Such prescribing is considered off-label and should not be interpreted as an officially approved indication.
Any off-label use should be based on appropriate clinical evidence, professional judgment, patient-specific assessment, and applicable guidelines. OL-TAP 200 MG TABLET should never be used for an unapproved purpose without specialist medical supervision.
Expert Advice
OL-TAP 200 MG TABLET is a prescription opioid medicine and should only be taken under qualified medical supervision.
The 200 mg ER strength requires careful dose selection and should not be used as a self-directed starting dose.
Swallow the extended-release tablet whole; do not alter the dosage form.
Never take more than the prescribed amount.
Do not combine the medicine with other prescription or non-prescription products unless your healthcare professional has confirmed that the combination is appropriate.
Long-term treatment should be reviewed periodically by the prescribing physician.
Keep the medicine securely stored and never share prescribed opioid medication with another person.
Tapentadol ER's pharmacological profile includes opioid receptor activity and central nervous-system effects, making adherence to the prescribed regimen particularly important.
Precautions
1. Prescription and controlled use
Tapentadol is subject to prescription controls in India. CDSCO records show its inclusion in Schedule H1, so it should be supplied and used according to applicable prescription requirements.
2. Extended-release formulation
Do not crush, chew, dissolve, or otherwise manipulate the tablet unless specifically permitted by the product's prescribing information. Altering a modified-release formulation can change drug delivery.
3. Dose selection
The 200 mg strength is a high-strength ER formulation. Dose selection and any subsequent adjustment should be determined by the prescribing physician rather than by the patient.
4. Other medicines and substances
Tell your healthcare professional about all medicines, supplements, and other substances you use before starting treatment. Tapentadol's central pharmacological activity makes medication review particularly important.
5. Discontinuation
If OL-TAP has been used regularly, do not stop treatment abruptly on your own. A healthcare professional should determine an appropriate discontinuation or dose-reduction plan.
6. Secure storage
Because Tapentadol is an opioid medicine, keep the tablets securely stored and inaccessible to children, visitors, and anyone for whom they were not prescribed.
Storage Conditions
Store according to the manufacturer's instructions printed on the packaging.
Keep in a cool, dry place away from excessive heat and moisture.
Protect the tablets from direct sunlight.
Keep them in their original packaging.
Store securely and out of reach of children.
Do not use the medicine after the expiry date printed on the package.
FAQs
1. What is OL-TAP 200 MG TABLET?
OL-TAP 200 MG TABLET contains Tapentadol 200 mg in an extended-release formulation. It belongs to the centrally acting opioid analgesic class.
2. What does ER mean in OL-TAP 200 MG?
ER means Extended Release. The formulation is designed to release Tapentadol gradually over an extended period rather than delivering the entire dose immediately.
3. What drug class does Tapentadol belong to?
Tapentadol is a centrally acting opioid analgesic with both mu-opioid receptor agonist and norepinephrine reuptake-inhibiting activity.
4. How does Tapentadol work?
Tapentadol acts through two principal mechanisms: mu-opioid receptor agonism and norepinephrine reuptake inhibition.
5. Can OL-TAP 200 MG TABLET be crushed or chewed?
No. Extended-release tablets should generally be swallowed whole. Do not crush or chew OL-TAP unless the specific product information provided by the manufacturer states otherwise.
6. Is OL-TAP 200 MG TABLET available without a prescription?
Tapentadol is a prescription-controlled medicine. In India, CDSCO records list Tapentadol under Schedule H1 requirements.
7. Can the dose be changed independently?
No. The 200 mg ER strength should be taken only according to the prescribing physician's instructions. Dose changes should be medically supervised.
8. How should OL-TAP 200 MG TABLET be stored?
Keep it in its original packaging in a cool, dry place away from heat, moisture, direct sunlight, and unauthorized access.
Suggested Product Tags
OL-TAP 200 MG TABLET, OL-TAP 200, Tapentadol ER 200 MG, Tapentadol 200 MG Tablet, Tapentadol Extended Release, Tapentadol Prolonged Release, Tapentadol ER Tablet, Tapentadol Hydrochloride, Opioid Analgesic, Centrally Acting Analgesic, Tapentadol Prescription Medicine, Tapentadol H1 Medicine, Extended Release Pain Medicine, Tapentadol 200 mg ER
